Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Cefotaxime
Drug ID BADD_D00390
Description Cefotaxime is a third-generation cephalosporin antibiotic. Like other third-generation cephalosporins, it has broad spectrum activity against Gram positive and Gram negative bacteria. In most cases, it is considered to be equivalent to ceftriaxone in terms of safety and efficacy. Cefotaxime sodium is marketed under various trade names including Claforan (Sanofi-Aventis).
Indications and Usage Used to treat gonorrhoea, meningitis, and severe infections including infections of the kidney (pyelonephritis) and urinary system. Also used before an operation to prevent infection after surgery.
Marketing Status Prescription; Discontinued
ATC Code J01DD01
DrugBank ID DB00493
KEGG ID D07647
MeSH ID D002439
PubChem ID 5742673
TTD Drug ID D0D1HA
NDC Product Code 0143-9933; 0143-9930; 0143-9935; 0143-9931
Synonyms Cefotaxime | Cephotaxim | Cefotaxim | Biosint | Cefotaxime Sodium | Sodium, Cefotaxime | Cefradil | Taporin | Fotexina | HR-756 | HR 756 | HR756 | Kendrick | Ru-24756 | Ru 24756 | Ru24756 | Benaxima | Claforan | Primafen | Klaforan
Chemical Information
Molecular Formula C16H17N5O7S2
CAS Registry Number 63527-52-6
SMILES CC(=O)OCC1=C(N2C(C(C2=O)NC(=O)C(=NOC)C3=CSC(=N3)N)SC1)C(=O)O
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Platelet count decreased13.01.04.0010.000319%
Pruritus23.03.12.0010.000319%
Pseudomembranous colitis11.02.02.002; 07.19.01.003--Not Available
Pulmonary congestion22.01.03.002; 02.05.02.002; 24.03.08.0010.000083%Not Available
Pyrexia08.05.02.0030.000958%
Rash23.03.13.0010.000319%Not Available
Rash erythematous23.03.06.0030.000213%Not Available
Rash generalised23.03.13.0020.000213%Not Available
Rash maculo-papular23.03.13.0040.000639%
Rash papular23.03.13.0170.000213%Not Available
Renal failure20.01.03.005--Not Available
Respiratory failure22.02.06.002; 14.01.04.0030.000213%
Seizure17.12.03.0010.000056%
Septic shock24.06.02.011; 11.01.11.0040.000083%Not Available
Shock24.06.02.0020.000213%Not Available
Skin exfoliation23.03.07.0030.000213%Not Available
Skin reaction23.03.03.013; 10.01.03.0190.000213%Not Available
Somnolence19.02.05.003; 17.02.04.0060.000213%
Stevens-Johnson syndrome12.03.01.014; 23.03.01.007; 11.07.01.005; 10.01.03.020--
Sudden death02.03.04.013; 08.04.01.0030.000056%
Superinfection11.01.08.009--Not Available
Syncope02.01.02.008; 24.06.02.012; 17.02.04.0080.000319%
Tachycardia02.03.02.0070.000056%Not Available
Tenderness08.01.08.005--Not Available
Thrombocytopenia01.08.01.0020.000319%Not Available
Torsade de pointes02.03.04.0050.000319%Not Available
Toxic epidermal necrolysis11.07.01.006; 10.01.01.006; 23.03.01.008; 12.03.01.0150.000056%
Urticaria23.04.02.001; 10.01.06.0010.000213%
Urticaria aquagenic23.04.02.006; 10.01.06.006--Not Available
Vaginal infection21.14.02.002; 11.01.10.002--
The 3th Page    First    Pre   3 4    Next   Last    Total 4 Pages